As of 2025-05-27, the EV/EBITDA ratio of Cardlytics Inc (CDLX) is -7.97. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Cardlytics's latest enterprise value is 257.89 mil USD. Cardlytics's TTM EBITDA according to its financial statements is -32.35 mil USD. Dividing these 2 quantities gives us the above Cardlytics EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 3.9x - 4.0x | 4.0x |
| Forward P/E multiples | 3.2x - 6.4x | 5.0x |
| Fair Price | (5.50) - (5.61) | (5.89) |
| Upside | -398.7% - -404.8% | -420.3% |
| Date | EV/EBITDA |
| 2025-05-23 | -7.97 |
| 2025-05-22 | -8.05 |
| 2025-05-21 | -7.96 |
| 2025-05-20 | -8.22 |
| 2025-05-19 | -8.20 |
| 2025-05-16 | -8.33 |
| 2025-05-15 | -8.22 |
| 2025-05-14 | -8.33 |
| 2025-05-13 | -8.39 |
| 2025-05-12 | -8.51 |
| 2025-05-09 | -8.13 |
| 2025-05-08 | -8.07 |
| 2025-05-07 | -8.49 |
| 2025-05-06 | -8.47 |
| 2025-05-05 | -8.46 |
| 2025-05-02 | -7.97 |
| 2025-05-01 | -7.43 |
| 2025-04-30 | -7.33 |
| 2025-04-29 | -7.33 |
| 2025-04-28 | -7.34 |
| 2025-04-25 | -7.44 |
| 2025-04-24 | -7.60 |
| 2025-04-23 | -7.51 |
| 2025-04-22 | -7.49 |
| 2025-04-21 | -7.38 |
| 2025-04-17 | -7.42 |
| 2025-04-16 | -7.42 |
| 2025-04-15 | -7.51 |
| 2025-04-14 | -7.28 |
| 2025-04-11 | -7.39 |
| 2025-04-10 | -7.26 |
| 2025-04-09 | -7.31 |
| 2025-04-08 | -6.98 |
| 2025-04-07 | -7.34 |
| 2025-04-04 | -7.26 |
| 2025-04-03 | -7.56 |
| 2025-04-02 | -7.94 |
| 2025-04-01 | -8.05 |
| 2025-03-31 | -7.94 |
| 2025-03-28 | -7.99 |
| 2025-03-27 | -8.25 |
| 2025-03-26 | -8.28 |
| 2025-03-25 | -8.48 |
| 2025-03-24 | -8.91 |
| 2025-03-21 | -9.01 |
| 2025-03-20 | -8.76 |
| 2025-03-19 | -8.68 |
| 2025-03-18 | -8.80 |
| 2025-03-17 | -8.84 |
| 2025-03-14 | -8.99 |